Request to Join
has invited you to join this group
Dr. A. Wesley Burks is Executive Dean for the UNC School of Medicine. In this role he is responsible for providing overall academic leadership for the School of Medicine and the UNC Health Care System. He is also the Curnen Distinguished Professor in teh Department of Pediatrics. Dr. Burks’ research interests are in the allergic diseases, particularly adverse reactions to foods. Dr. Burks’ heads a research team whose work centers on the molecular identification of the allergens in specific foods, a better understanding of the mechanism of adverse food reactions, and the development of treatment for food allergy in animal models and in clinical studies. Dr. Burks and his colleagues have several ongoing clinical studies with different types of mucosal immunotherapy. His laboratory funding comes from many sources, including the National Institutes of Health and private foundations. Dr. Burks has been published in many distinguished journals and has authored or coauthored numerous articles, chapters and abstracts. He is a past Chair and member of the NIH Hypersensitivity, Autoimmune, and Immune-mediated Diseases study section and is Past President of the American Academy of Allergy, Asthma and Immunology. Dr. Burks graduated from the University of Central Arkansas and then the University of Arkansas for Medical Sciences. He completed a pediatric residency at the Arkansas Children’s Hospital. Dr. Burks subsequently completed a fellowship in allergy and immunology at Duke University Medical Center. He was previously on the faculty at the University of Arkansas for Medical Sciences and Arkansas Children’s Hospital and Duke University Medical Center.
Jonathan Hourihane has been Professor of Paediatrics and Child Health in University College Cork, Ireland since 2005. He graduated from Trinity College Dublin in 1987. He undertook his higher training in Southampton, and London, UK. His primary area of clinical and research interest is in paediatric food allergy and anaphylaxis. He is co-Principal Investigator of the BASELINE, Ireland’s only birth cohort study (www.baselinestudy.net.) and the INFANT Research Centre in UCC. He was a Board member of RCPI Faculty of Paediatrics 2015-2018. He is a Board member of the National Childrens Research Centre, Ireland and is a member of the NCRC Strategy Committee. He is a founding Board member of the Clemens von Pirquet Foundation, and of the Irish Food Allergy Network (www.ifan.ie). He is current President of the Irish Association of Allergy and Immunology.
Dr. Brian Vickery is a pediatric allergist-immunologist whose clinical and research efforts focus on an improved understanding of food allergies and anaphylaxis and the development of novel therapies. Dr. Dr. Vickery completed his undergraduate work at the University of Georgia and then obtained his medical degree from the Medical College of Georgia. He completed pediatric residency at New York-Presbyterian Hospital/Weill Cornell in New York City, and was selected as a chief resident. He then completed his fellowship training in allergy & clinical immunology at Yale University School of Medicine and while there worked on the preclinical development of EMP-123, a novel recombinant protein immunotherapy for peanut allergy. He then joined the faculty at Duke University and the research group of Dr. Wesley Burks, where he worked for four years before moving to UNC as an assistant professor with Dr. Burks in 2012. While at UNC, Dr. Vickery was an NIH-funded researcher and the Director of the UNC Food Allergy Initiative, whose work focused on understanding the biology of food allergy and developing novel therapies. He was first to show the development of sustained unresponsiveness after peanut oral immunotherapy and was the PI of the DEVIL study, the first to focus on early treatment in very young peanut-allergic children.